RSC Advances
Paper
for C15H21NO4: C, 64.50; H, 7.58; N, 5.01. Found: C, 64.24; H, 7.43 (m, 5H, Bn-ArH); 13C NMR (75 MHz, CDCl3) d 28.2, 37.3,
7.57; N, 5.02%.
52.0, 54.4, 69.9, 79.7, 114.8, 127.3, 127.8, 128.2, 128.4, 130.2,
136.9, 146.6, 157.8, 172.28. Anal. calcd for C22H27NO5: C, 68.55;
H, 7.06; N, 3.63. Found: C, 68.82; H, 7.04; N, 3.62%.
N-Boc-L-leucine methyl ester (5c)
Following the general procedure, compound 5c was prepared
from N-nosyl-L-leucine methyl ester 1c. Obtained as a viscous
colorless oil (139.4 mg, 95% yield): 1H NMR (300 MHz, CDCl3) d
0.83 [d, J ¼ 6.3 Hz, 3H, CH2CH(CH3)2], 0.85 [d, J ¼ 6.3 Hz, 3H,
CH2CH(CH3)2], 1.32 (s, 9H, t-Bu), 1.39–1.68 [m, 3H,
CH2CH(CH3)2, CH2CH(CH3)2], 3.64 (s, 3H, OCH3), 4.22 (dt, J ¼
8.7 and 6.9 Hz, 1H, a-CH), 4.98 (d, J ¼ 8.4 Hz, 1H, NH); 13C NMR
(75 MHz, CDCl3) d 21.6, 22.6, 24.5, 27.2, 28.1, 41.5, 51.9, 79.5,
155.3, 173.9. GC/MS (EI): m/z (%) 186 (15), 172 (2), 144 (12), 130
(57), 86 (100), 57 (73). Anal. calcd for C12H23NO4: C, 58.75; H,
9.45; N, 5.71. Found: C, 58.97; H, 9.43; N, 5.69%.
N-Boc-L-cysteine(SBn) methyl ester (5h)
Following the general procedure, compound 5h was prepared
from N-nosyl-L-cysteine(SBn) methyl ester 1h. Obtained as a
viscous colorless oil (147.1 mg, 92% yield): H NMR (300 MHz,
CDCl3) d 1.36 (s, 9H, t-Bu), 2.56 (dd, J ¼ 13.9 and 5.1 Hz, 1H,
CH2SBn), 2.61 (dd, J ¼ 13.9 and 5.1 Hz, 1H, CH2SBn), 3.62 (s, 2H,
SCH2Ph), 3.64 (s, 3H, OCH3), 4.43 (dt, J ¼ 7.8 and 5.1 Hz, 1H, a-
CH), 5.21 (d, J ¼ 7.8 Hz, 1H, NH), 7.08–7.28 (m, 5H, ArH). 13C
NMR (75 MHz, CDCl3) d 28.2, 33.5, 36.5, 52.6, 53.0, 80.0, 127.1,
128.5, 128.9, 137.6, 155.1, 171.5. Anal. calcd for C16H23NO4S: C,
59.05; H, 7.12; N, 4.30. Found: C, 59.27; H, 7.10; N, 4.29%.
1
N-Boc-L-isoleucine methyl ester (5d)
N-Boc-L-phenylalanyl-L-alanine methyl ester (8)
Following the general procedure, compound 5d was prepared
from N-nosyl-L-isoleucine methyl ester 1d. Obtained as a viscous
colorless oil (138.7 mg, 94% yield): 1H NMR (300 MHz, CDCl3) d
0.81 [t, J ¼ 7.2 Hz, 3H, CH(CH3)CH2CH3], 0.82 [d, J ¼ 6.9 Hz, 3H,
CH(CH3)CH2CH3], 1.08 (m, 1H, CH(CH3)CH2CH3], 1.32 [m, 1H,
CH(CH3)CH2CH3], 1.34 (s, 9H, t-Bu), 1.72 (m, 1H, CH(CH3)
CH2CH3], 3.63 (s, 3H, OCH3), 4.13 (m, 1H, a-CH), 5.01 (s broad,
1H, NH); 13C NMR (75 MHz, CDCl3) d 11.3, 15.3, 24.9, 28.1, 37.9,
51.7, 57.7, 79.5, 155.4, 172.6. GC/MS (EI): m/z (%) 186 (24), 172
(3), 144 (17), 130 (92), 86 (78), 57 (100). Anal. calcd for
Following the general procedure, compound 8 was prepared
from N-nosyl-L-phenylalanyl-L-alanine methyl ester 10a.
Obtained asa viscous colorless oil (148.1 mg, 92% yield): 1H NMR
(300 MHz, CDCl3) d 1.28 (d, 3H, J ¼ 7.2 Hz, CHCH3), 1.33 (s, 9H,
tBu), 2.88–3.09 (m, 2H, CH2Ph), 3.63 (s, 3H, OCH3), 4.38 (m, 1H,
a-CHPhe), 4.47 (quintet, J ¼ 7.2 Hz, a-CHAla), 5.29 (d, 1H, J ¼ 8.2
Hz, NHCHCH3), 6.84 (s broad, 1H, OCONH), 7.10–7.23 (m, 5H,
ArH); 13C NMR (75 MHz, CDCl3) d 17.8, 28.1, 38.3, 47.9, 52.1, 55.7,
79.8, 126.6, 128.3, 129.2, 136.6, 155.4, 171.0, 172.7. GC/MS (EI):
m/z (%) 294 (5), 277 (3), 233 (10), 174 (11), 164 (37), 159 (21), 120
(90), 91 (19), 77 (4), 57 (100). Anal. calcd for C18H26N2O5: C, 61.70;
H, 7.48; N, 7.99. Found: C, 61.48; H, 7.50; N, 7.97%.
C
12H23NO4: C, 58.75; H, 9.45; N, 5.71. Found: C, 58.53; H, 9.49;
N, 5.72%.
N-Boc-L-alanine methyl ester (5e)
N-Boc-D-phenylalanyl-L-alanine methyl ester (9)
Following the general procedure, compound 5e was prepared
from N-nosyl-L-alanine methyl ester 1e. Obtained as a viscous
colorless oil (132.1 mg, 94% yield): 1H NMR (300 MHz, CDCl3) d
1.35 (d, J ¼ 7.2 Hz, 3H, CHCH3), 1.41 (s, 9H, t-Bu), 3.71 (s, 3H,
OCH3), 4.27 (quintet, J ¼ 7.2 Hz, 1H, a-CH), 5.05 (s broad, 1H,
NH); 13C NMR (75 MHz, CDCl3) d 18.4, 28.1, 48.1, 52.1, 79.6,
155.2, 172.8. GC/MS (EI): m/z (%) 144 (52), 130 (9), 116 (6), 102
(16), 88 (40), 59 (36), 57 (100). Anal. calcd for C9H17NO4: C,
53.19; H, 8.43; N, 6.89. Found: C, 53.39; H, 8.44; N, 6.87%.
Following the general procedure, compound 9 was prepared
from N-nosyl-D-phenylalanyl-L-alanine methyl ester 10b.
Obtained as a viscous colorless oil (151.3 mg, 95% yield): 1H
NMR (300 MHz, CDCl3) d 1.21 (d, 3H, J ¼ 7.3 Hz, CHCH3), 1.34
(s, 9H, tBu), 2.93–3.07 (m, 2H, CH2Ph), 3.64 (s, 3H, OCH3), 4.35
(m, 1H, a-CHPhe), 4.46 (quintet, J ¼ 7.3 Hz, 1H, a-CHAla), 5.31
(d, J ¼ 8.1 Hz, NHCHCH3, 1H), 6.58 (d, J ¼ 7.3 Hz, 1H, OCONH),
7.11–7.24 (m, 5H, ArH); GC/MS (EI): m/z (%) 294 (5), 277 (3), 233
(11), 174 (12), 164 (41), 159 (20), 120 (92), 91 (21), 77 (4), 57 (100).
13C NMR (75 MHz, CDCl3) d 17.8, 28.1, 38.3, 47.9, 52.0, 55.6,
79.9, 126.6, 128.4, 129.2, 136.7, 155.2, 170.8, 172.8. Anal. calcd
for C18H26N2O5: C, 61.70; H, 7.48; N, 7.99. Found: C, 61.60; H,
7.46; N, 8.01%.
N-Boc-D-phenylalanine methyl ester (5f)
Following the general procedure, compound 5f was prepared
from N-nosyl-D-phenylalanine methyl ester 1f. Obtained as a
viscous colorless oil (148 mg, 96% yield). Anal. calcd for
C
15H21NO4: C, 64.50; H, 7.58; N, 5.01. Found: C, 64.70; H, 7.56;
N, 5.00%.
N-Boc-L-leucyl-L-alanine methyl ester (11)
Following the general procedure, compound 11 was prepared
N-Boc-L-tyrosine(OBn) methyl ester (5g)
from N-nosyl-L-leucyl-L-alanine methyl ester 10c. Obtained as a
1
Following the general procedure, compound 5g was prepared viscous colorless oil (185.4 mg, 94% yield): H NMR (300 MHz,
from N-nosyl-L-tyrosine(OBn) methyl ester 1g. Obtained as a CDCl3) d 0.90 [d, J ¼ 6.2 Hz, 3H, CH2CH(CH3)2], 0.91 [d, J ¼ 6.2
1
viscous colorless oil (150.4 mg, 93% yield): H NMR (300 MHz, Hz, 3H, CH2CH(CH3)2], 1.39 (d, J ¼ 7.5 Hz, 3H, CHCH3), 1.49
CDCl3) d 1.39 (s, 9H, t-Bu), 3.02 (m, 2H, CHCH2), 3.69 (s, 3H, (s, 9H, tBu), 1.52–1.73 [m, 3H, CH2CH(CH3)2, CH2CH(CH3)2],
OCH3), 4.55 (m, 1H, a-CH), 5.02 (s, 2H, CH2Ph), 6.89 (d, J ¼ 8.7 3.73 (s, 3H, OCH3), 4.40–4.49 (m, 1H, a-CHLeu), 4.52 (quintet,
Hz, 2H, o-OBnArH), 7.03 (d, J ¼ 8.7 Hz, 2H, m-OBnArH), 7.27– J ¼ 7.5 Hz, 1H, a-CHAla), 6.73 (m, 2H, OCONH, NHCHCH3);
2684 | RSC Adv., 2014, 4, 2678–2686
This journal is © The Royal Society of Chemistry 2014